Gene therapy: Reprogramming α -cells reverses diabetes
Nature Reviews Drug Discovery 17, 93 (2018).
doi:10.1038/nrd.2018.7
Author: Sarah Crunkhorn
Autoimmune destruction of insulin (INS)-producing pancreatic β-cells, resulting in persistent hyperglycaemia, underlies the pathogenesis of type 1 diabetes. Preserving and restoring functional β-cell mass is therefore a fundamental objective of diabetes therapy. Writing in Cell Stem Cell, Gittes and colleagues report the successful conversion
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Sarah Crunkhorn Tags: Research Highlight Source Type: research
More News: Diabetes | Diabetes Type 1 | Drugs & Pharmacology | Endocrinology | Gene Therapy | Genetics | Insulin | Pancreas | Stem Cell Therapy | Stem Cells